| 000 | 05250cam a2200721Ii 4500 | ||
|---|---|---|---|
| 001 | on1075551100 | ||
| 003 | OCoLC | ||
| 005 | 20220711203536.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 181115s2019 nju ob 001 0 eng | ||
| 010 | _a 2018055054 | ||
| 040 |
_aDLC _beng _erda _epn _cDLC _dOCLCO _dOCLCF _dN$T _dDG1 _dUKMGB _dYDX _dOCLCO _dOCLCQ _dUKAHL _dNOC _dOCLCA |
||
| 015 |
_aGBB930650 _2bnb |
||
| 016 | 7 |
_a019252779 _2Uk |
|
| 019 |
_a1091235002 _a1091694315 _a1100456348 |
||
| 020 |
_a9781119285519 _q(electronic bk.) |
||
| 020 |
_a1119285518 _q(electronic bk.) |
||
| 020 |
_a9781119600800 _q(electronic bk.) |
||
| 020 |
_a1119600804 _q(electronic bk.) |
||
| 020 |
_a9781119285502 _q(ePub ebook) |
||
| 020 | _a111928550X | ||
| 020 |
_z9781119285496 _q(hardcover) |
||
| 020 | _z1119285496 | ||
| 029 | 1 |
_aAU@ _b000065219609 |
|
| 029 | 1 |
_aCHNEW _b001050852 |
|
| 029 | 1 |
_aCHVBK _b567422054 |
|
| 029 | 1 |
_aUKMGB _b019252779 |
|
| 035 |
_a(OCoLC)1075551100 _z(OCoLC)1091235002 _z(OCoLC)1091694315 _z(OCoLC)1100456348 |
||
| 037 |
_a9781119285502 _bWiley |
||
| 050 | 4 | _aRS192 | |
| 060 | 4 | _aQV 778 | |
| 072 | 7 |
_aMED _x071000 _2bisacsh |
|
| 082 | 0 | 4 |
_a615.1/9 _223 |
| 049 | _aMAIN | ||
| 245 | 0 | 0 |
_aChemical engineering in the pharmaceutical industry : _bdrug product design, development and modeling / _cedited by Mary Tanya am Ende, Global R & D, Pfizer, Inc., Groton, CT, USA, David J. am Ende, Nalas Engineering Services, Inc., Centerbrook, CT, USA. |
| 250 | _aSecond edition. | ||
| 264 | 1 |
_aHoboken, NJ, USA : _bWiley, _c2019. |
|
| 300 | _a1 online resource | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bn _2rdamedia |
||
| 338 |
_aonline resource _bnc _2rdacarrier |
||
| 588 | 0 | _aOnline resource; title from PDF title page (EBSCO, viewed April 8, 2019) | |
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aPreface; Contributors; Unit Conversions and Commonly used Formulas; Part I Introduction; Chapter 1 Chemical Engineering in the Pharmaceutical Industry: An Introduction; Part II Drug Product Design, Development & Modeling; Chapter 2 Design of Solid Dosage Formulations; Chapter 3 Powder Process Challenges and Solutions; Chapter 4 Design and Scale-up of Dry Granulation Processes; Chapter 5 Model based development of roller compaction processes; Chapter 6 Wet Granulation Processes; Chapter 7 Towards a generic model for twin-screw wet granulation; Chapter 8 Modeling a dosator capsule filling process for hard-shell capsules; Chapter 9 Powder Compaction -- Process Design and Understanding; Chapter 10 Punch Sticking: Factors and Solutions; Chapter 11 Spray Atomization Modeling for Tablet Film Coating Processes; Chapter 12 Spray Drying and Amorphous Dispersions; Chapter 13 The Freeze Drying Process: The Use of Mathematical Modeling in Process Design, Understanding and Scale-up; Chapter 14 Sterilization Processes in the Pharmaceutical Industry; Chapter 15 Controlled Release Technology and Design of Oral Controlled Release Dosage Forms; Chapter 16 Process Design and Development for Novel Pharmaceutical Dosage Forms; Chapter 17 Multiscale Modeling of a Pharmaceutical Fluid-bed Coating Process: Using CFD/DEM and Population-balance Models to Predict Coating Uniformity; Chapter 18 Process Design of Topical Semi-solids: Application of Fundamental Concepts in Pharmaceutical Engineering to PEG Ointment Development; Chapter 19 Achieving a Hot Melt Extrusion Design Space for the Production of Solid Solutions; Chapter 20 Drug Product Process Modeling; Part III Continuous Manufacturing; Chapter 21 Continuous Manufacturing in Secondary Production; Chapter 22 Continuous Direct Compression Using Portable Continuous Miniature Modular & Manufacturing (PCM & M); Chapter 23 Process control levels for continuous pharmaceutical tablet manufacturing; Part IV Applied Statistics / Regulatory Environment; Chapter 24 Multivariate Analysis for Pharmaceutical and Medical Device Development; Chapter 25 Pharmaceutical Manufacturing: The Role of Multivariate Analysis in Design Space, Control Strategy, Process Understanding, Troubleshooting, and Optimization; Chapter 26 Quality by Design: Pilot to Reality -- The Honeymoon Phase to the Stormy Years | |
| 650 | 0 |
_aPharmaceutical technology. _97812 |
|
| 650 | 0 |
_aBiochemical engineering. _93861 |
|
| 650 | 0 |
_aChemical engineering. _93585 |
|
| 650 | 2 |
_aTechnology, Pharmaceutical. _0(DNLM)D013678 _98637 |
|
| 650 | 2 |
_aChemical Engineering. _0(DNLM)D002616 _93585 |
|
| 650 | 2 |
_aDrug Industry _xmethods. _0(DNLM)D004345Q000379 _98638 |
|
| 650 | 7 |
_aMEDICAL _xPharmacology. _2bisacsh _98639 |
|
| 650 | 7 |
_aBiochemical engineering. _2fast _0(OCoLC)fst00831936 _93861 |
|
| 650 | 7 |
_aChemical engineering. _2fast _0(OCoLC)fst00852893 _93585 |
|
| 650 | 7 |
_aPharmaceutical technology. _2fast _0(OCoLC)fst01060211 _97812 |
|
| 655 | 4 |
_aElectronic books. _93294 |
|
| 700 | 1 |
_aEnde, Mary Tanya am, _eeditor. _98640 |
|
| 700 | 1 |
_aEnde, David J. am, _eeditor. _98641 |
|
| 776 | 0 | 8 |
_iPrint version: _tChemical engineering in the pharmaceutical industry. _bSecond edition. _dHoboken, NJ, USA : Wiley, 2019 _w(DLC) 2018054741 |
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/9781119600800 _zWiley Online Library |
| 942 | _cEBK | ||
| 994 |
_aC0 _bDG1 |
||
| 999 |
_c69158 _d69158 |
||